Smart Insulin or Glucose Responsive Insulin Market to Reach $6.17 Bn, Globally, by 2027 at 10.5% CAGR: Allied Market Research

Increase in incidence and prevalence of diabetes, rise in healthcare expenditure, and surge in adoption of technologically advanced products drive the growth of the global smart insulin market.

News provided by

Allied Market Research

Aug 17, 2020, 09:30 ET

PORTLAND, Ore., Aug. 17, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Smart Insulin or Glucose Responsive Insulin Market by Delivery Devices (Smart Insulin Pen and Smart Insulin Pump), Disease, (Type 1 Diabetes and Type 2 Diabetes), and Type (Rapid Acting, Intermediate Acting, Long Acting, Short Acting, and Premixed Type): Global Opportunity Analysis and Industry Forecast, 2019–2027." According to the report, the global smart insulin or glucose responsive insulin industry was estimated at $2.77 billion in 2019, and is expected to hit $6.17 billion by 2027, registering a CAGR of 10.5% from 2020 to 2027.

Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/1674?reqfor=covid

Drivers, restraints, and opportunities-

Increase in incidence and prevalence of diabetes, rise in healthcare expenditure, and surge in adoption of technologically advanced products drive the growth of the global smart insulin or glucose responsive insulin market. On the other hand, adverse effects and several safety issues with the devices impede the growth to some extent. Nevertheless, rise in awareness toward smart insulin devices and untapped opportunities & undiagnosed population in developing regions are expected to create multiple opportunities in the industry.

Covid-19 scenario-

There's been a slow growth in the global smart insulin market. Disruptions in supply chains and restrictions on trade of advance medical products across countries during lockdown have impacted the market negatively.
Nevertheless, with several government bodies bringing in relaxations on the current regulations, the global market is projected to regain its position soon.

The smart insulin pump segment to dominate by 2027-

Based on delivery device, the global smart insulin pump segment accounted for 96% of the global smart insulin or glucose responsive insulin market share in 2019 and is expected to lead the trail by 2027. Surge in demand for home infusion therapy and advancements in traditional insulin pumps are expected to propel the growth of the segment. The smart insulin pen segment, on the other hand, would register the fastest CAGR of 12.2% throughout the forecast period. Increase in demand for minimally invasive devices boosts the segment growth.

The type 1 diabetes segment to rule the roost-

Based on disease, the type 1 diabetes segment contributed to more than three-fifths of the global smart insulin or glucose responsive insulin market revenue in 2019 and is projected to retain its dominance by the end of 2027, owing to the presence of large pool of patients suffering from this condition. Simultaneously, the type 2 diabetes segment would portray the fastest CAGR of 11.1% during the study period. This is due to increasing prevalence of diabetes 2 and growing product approvals for treating the condition.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1674

North America garnered the highest share in 2019-

Based on geography, North America held the major share in 2019, generating nearly two-fifths of global smart insulin or glucose responsive insulin market. With more and more patients opting for advanced diabetes treatments in this province, the market growth has increased to a significant extent. At the same time, Asia-Pacific would manifest the fastest CAGR of 13.0% from 2020 to 2027, due to increase in diabetic population across the region.

Frontrunners in the industry-

Diamesco Co
Eli lily and Company
Zealand Pharma
F. Hoffmann-La Roche AG
Novo Nordisk A/S
Insulet Corporation
Medtronic Plc
CeQur
Sanofi

Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at:

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Human Insulin Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Self-Monitoring Blood Glucose Strips Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Sangers Sequencing Service Market - Global Opportunity Analysis and Industry Forecast, 2019–2026

Smart Hospitals Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Occupational Medicines Market - Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]